{"mainPropery":{"diseaseId":3584,"diseaseName":"Methylmalonic acidemia with homocystinuria type cblF","hasGardWebPage":false,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/3584/methylmalonic-acidemia-with-homocystinuria-type-cblf","synonyms":["Combined defect in adenosylcobalamin and methylcobalamin synthesis, type cblF","Methylmalonic aciduria with homocystinuria, type cblF"],"synonyms-with-source":[{"name":"Combined defect in adenosylcobalamin and methylcobalamin synthesis, type cblF","source":"Orphanet"},{"name":"Methylmalonic aciduria with homocystinuria, type cblF","source":"Orphanet"}],"identifiers":[{"identifierType":"OMIM","identifierId":"277380"},{"identifierType":"ORPHANET","identifierId":"79284"}]},"diseaseCategories":[{"diseaseTypeId":12,"diseaseTypeName":"Blood Diseases","source":"Orphanet"},{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":14,"diseaseTypeName":"Metabolic disorders"}],"organizations":[{"resourceID":221,"resourceName":"Organic Acidemia Association","abbreviation":"","address1":"9040 Duluth Street","address2":"","address3":"","address4":"","address5":"","city":"Golden Valley","state":"MN","zip":"55427","country":"United States","phone":"763-559-1797","tty":"","tollFree":"","fax":"866-539-4060","email":"mkstagni@gmail.com","url":"http://www.oaanews.org/","freeText":""},{"resourceID":3595,"resourceName":"HCU Network America","abbreviation":"","address1":"623 Creek Lane","address2":"","address3":"","address4":"","address5":"","city":"Flourtown","state":"PA","zip":"19031","country":"United States","phone":"630-360-2087","tty":"","tollFree":"","fax":"","email":"info@hcunetworkamerica.org","url":"http://hcunetworkamerica.org/","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/277380' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/condition/methylmalonic-acidemia-with-homocystinuria' target='_blank'>Genetics Home Reference (GHR)</a> contains information on Methylmalonic acidemia with homocystinuria type cblF. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":350,"resourceId":1167,"resourceName":"Baby's First Test","descriptionText":"<a href='https://www.babysfirsttest.org/newborn-screening/conditions/methylmalonic-acidemia-with-homocystinuria' target='_blank'>Baby's First Test</a> is the nation's newborn screening education center for families and providers. This site provides information and resources about screening at the local, state, and national levels and serves as the Clearinghouse for newborn screening information.","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Newborn Screening"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1526,"resourceId":2158,"resourceName":"Genetic Testing Registry","descriptionText":"The <a href='http://www.ncbi.nlm.nih.gov/gtr/conditions/C1848578/' target='_blank'>Genetic Testing Registry</a> (GTR) provides information about the genetic tests for this condition. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\r\n","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/947154-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=79284' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1537,"resourceId":2168,"resourceName":"GeneReviews","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/books/NBK1328/' target='_blank'>GeneReviews</a> provides current, expert-authored, peer-reviewed, full-text articles describing the application of genetic testing to the diagnosis, management, and genetic counseling of patients with specific inherited conditions.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:277380' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":7359,"questionText":"What is methylmalonic aciduria with homocystinuria cbl f?","answerText":"<strong>Methylmalonic aciduria with homocystinuria cbl f</strong> is a form of <a href=\"http://rarediseases.info.nih.gov/gard/3579/methylmalonic-acidemia-with-homocystinuria/resources/1\">methylmalonic acidemia with homocystinuria</a>, an inborn error of vitamin B12 (cobalamin) metabolism that can&nbsp;cause the following signs and symptoms: megaloblastic anemia, lack of energy, growth delays, developmental delay, intellectual&nbsp;disability and seizures. The appearance of signs and symptoms can vary from birth to 11 years old. The disorder is caused by mutations in the <span class=\"italicText\"><a href=\"http://ghr.nlm.nih.gov/gene/LMBRD1\">LMBRD1</a></span> gene and is transmitted in an <a href=\"http://ghr.nlm.nih.gov/handbook/illustrations/autorecessive\">autosomal recessive manner</a>. Treatment options include vitamin B12 injections and dietary management.[7241][5275]<br />\r\n<br />","dateModified":"2014-03-05T13:28:00"},"basicQuestions":[{"questionId":7360,"questionText":"How is methylmalonic aciduria with homocystinuria cbl f diagnosed?","answerText":"The diagnosis of disorders of methylmalonic aciduria with homocystinuria cbl f&nbsp;relies on clinical exams and biochemical testing (urine organic acid analysis and plasma amino acid analysis). Diagnosis is confirmed by genetic testing.[5275] To view a list of labs offering genetic testing for this condition, please visit the \"Tests and Diagnosis\" section: <a href=\"http://rarediseases.info.nih.gov/gard/3584/methylmalonic-aciduria-with-homocystinuria-cbl-f/resources/12\">http://rarediseases.info.nih.gov/gard/3584/methylmalonic-aciduria-with-homocystinuria-cbl-f/resources/12</a>","dateModified":"2014-03-05T13:45:00","resourceClassificationName":"Diagnosis","references":[{"referenceId":5275,"authors":"Manoli I, Sloan JL, Venditti CP","articleTitle":"Isolated Methylmalonic Acidemia","bookWebsiteJournalTitle":"GeneReviews","date":"January 7, 2016","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1231/","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":7361,"questionText":"How might methylmalonic aciduria with homocystinuria cbl f be treated?","answerText":"Treatment for methylmalonic aciduria with homocystinuria cbl f may involve a combination of vitamin B12 injections and dietary management such as a low-protein diet and medical formula. The following fact sheet for parents prepared by Screening, Technology and Research in Genetics provides additional information on the treatment and management of methylmalonic aciduria with homocystinuria.&nbsp;<a href=\"http://www.newbornscreening.info/Parents/organicaciddisorders/MMA_HCU.html#4\">http://www.newbornscreening.info/Parents/organicaciddisorders/MMA_HCU.html#4&nbsp;</a>","dateModified":"2014-03-05T13:56:00","resourceClassificationName":"Treatment","references":[]}],"references":[{"referenceId":7241,"authors":"Rosenblaat D and Watkins D","articleTitle":"Methylmalonic acidemia with homocystinuria, type cblF","bookWebsiteJournalTitle":"Orphanet","date":"March, 2012","volume":"","pages":"","url":"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&Expert=79284","dateAccessed":"2014-03-05T00:00:00","authors2":"","placeOfPublication":"","publisher":""}],"relatedDiseases":[{"relatedDiseaseId":3579,"relatedDiseaseName":"Methylmalonic acidemia with homocystinuria","relation":"Parent","isRare":true,"hasGardPage":true}],"gardCases":[{"caseId":44093,"abbreviatedInquiry":"I have a cousin in China, who sadly lost his 5-month second daughter about a week ago, who died of \"combined methylmalonic aciduria and homocystinuria\".\r\n\r\nMy cousin is very concerned about his older daughter, who is now 3.5 years old and healthy, because he has heard that this type of genetic disease could be \"late-onset\".\r\n\r\nCould you help me find latest info of research and treatment on this disease, especially on screening, diagnosis and treatment of \"late-onset\" \"combined methylmalonic aciduria and homocystinuria\".\r\n\r\nAny help is much appreciated! Thank you for your time.","caseQuestions":[{"questionId":7359,"questionText":"What is methylmalonic aciduria with homocystinuria cbl f?","answerText":"<strong>Methylmalonic aciduria with homocystinuria cbl f</strong> is a form of <a href=\"http://rarediseases.info.nih.gov/gard/3579/methylmalonic-acidemia-with-homocystinuria/resources/1\">methylmalonic acidemia with homocystinuria</a>, an inborn error of vitamin B12 (cobalamin) metabolism that can&nbsp;cause the following signs and symptoms: megaloblastic anemia, lack of energy, growth delays, developmental delay, intellectual&nbsp;disability and seizures. The appearance of signs and symptoms can vary from birth to 11 years old. The disorder is caused by mutations in the <span class=\"italicText\"><a href=\"http://ghr.nlm.nih.gov/gene/LMBRD1\">LMBRD1</a></span> gene and is transmitted in an <a href=\"http://ghr.nlm.nih.gov/handbook/illustrations/autorecessive\">autosomal recessive manner</a>. Treatment options include vitamin B12 injections and dietary management.[7241][5275]<br />\r\n<br />","dateModified":"2014-03-05T13:28:00","references":[{"referenceId":5275,"authors":"Manoli I, Sloan JL, Venditti CP","articleTitle":"Isolated Methylmalonic Acidemia","bookWebsiteJournalTitle":"GeneReviews","date":"January 7, 2016","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1231/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":7241,"authors":"Rosenblaat D and Watkins D","articleTitle":"Methylmalonic acidemia with homocystinuria, type cblF","bookWebsiteJournalTitle":"Orphanet","date":"March, 2012","volume":"","pages":"","url":"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&Expert=79284","dateAccessed":"2014-03-05T00:00:00","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":7360,"questionText":"How is methylmalonic aciduria with homocystinuria cbl f diagnosed?","answerText":"The diagnosis of disorders of methylmalonic aciduria with homocystinuria cbl f&nbsp;relies on clinical exams and biochemical testing (urine organic acid analysis and plasma amino acid analysis). Diagnosis is confirmed by genetic testing.[5275] To view a list of labs offering genetic testing for this condition, please visit the \"Tests and Diagnosis\" section: <a href=\"http://rarediseases.info.nih.gov/gard/3584/methylmalonic-aciduria-with-homocystinuria-cbl-f/resources/12\">http://rarediseases.info.nih.gov/gard/3584/methylmalonic-aciduria-with-homocystinuria-cbl-f/resources/12</a>","dateModified":"2014-03-05T13:45:00","resourceClassificationName":"Diagnosis","references":[{"referenceId":5275,"authors":"Manoli I, Sloan JL, Venditti CP","articleTitle":"Isolated Methylmalonic Acidemia","bookWebsiteJournalTitle":"GeneReviews","date":"January 7, 2016","volume":"","pages":"","url":"http://www.ncbi.nlm.nih.gov/books/NBK1231/","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":7361,"questionText":"How might methylmalonic aciduria with homocystinuria cbl f be treated?","answerText":"Treatment for methylmalonic aciduria with homocystinuria cbl f may involve a combination of vitamin B12 injections and dietary management such as a low-protein diet and medical formula. The following fact sheet for parents prepared by Screening, Technology and Research in Genetics provides additional information on the treatment and management of methylmalonic aciduria with homocystinuria.&nbsp;<a href=\"http://www.newbornscreening.info/Parents/organicaciddisorders/MMA_HCU.html#4\">http://www.newbornscreening.info/Parents/organicaciddisorders/MMA_HCU.html#4&nbsp;</a>","dateModified":"2014-03-05T13:56:00","resourceClassificationName":"Treatment","references":[]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":4081,"phenoTypeName":"Failure to thrive","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":3410,"phenoTypeName":"Feeding difficulties in infancy","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8721,"phenoTypeName":"Lethargy","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":13085,"phenoTypeName":"Megaloblastic bone marrow","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8716,"phenoTypeName":"Muscular hypotonia","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8719,"phenoTypeName":"Seizure","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8270,"phenoTypeName":"Skin rash","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8672,"phenoTypeName":"Stomatitis","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":8720,"phenoTypeName":"Ataxia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":5154,"phenoTypeName":"Developmental regression","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":6006,"phenoTypeName":"Psychosis","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":4,"phenoTypeName":"Autosomal recessive inheritance","percentRanges":"-"},{"phenoTypeId":10972,"phenoTypeName":"Cystathioninemia","percentRanges":"-"},{"phenoTypeId":14591,"phenoTypeName":"Cystathioninuria","percentRanges":"-"},{"phenoTypeId":14585,"phenoTypeName":"Decreased adenosylcobalamin","percentRanges":"-"},{"phenoTypeId":13621,"phenoTypeName":"Decreased methionine synthase activity","percentRanges":"-"},{"phenoTypeId":14523,"phenoTypeName":"Decreased methylcobalamin","percentRanges":"-"},{"phenoTypeId":9886,"phenoTypeName":"Epicanthus","percentRanges":"-"},{"phenoTypeId":9384,"phenoTypeName":"Generalized hypotonia","percentRanges":"-"},{"phenoTypeId":8723,"phenoTypeName":"Global developmental delay","percentRanges":"-"},{"phenoTypeId":14203,"phenoTypeName":"Glossitis","percentRanges":"-"},{"phenoTypeId":14212,"phenoTypeName":"High palate","percentRanges":"-"},{"phenoTypeId":13835,"phenoTypeName":"Homocystinuria","percentRanges":"-"},{"phenoTypeId":13836,"phenoTypeName":"Hyperhomocystinemia","percentRanges":"-"},{"phenoTypeId":11393,"phenoTypeName":"Incoordination","percentRanges":"-"},{"phenoTypeId":6245,"phenoTypeName":"Infantile onset","percentRanges":"-"},{"phenoTypeId":11305,"phenoTypeName":"Low-set ears","percentRanges":"-"},{"phenoTypeId":15527,"phenoTypeName":"Megaloblastic anemia","percentRanges":"-"},{"phenoTypeId":4320,"phenoTypeName":"Methylmalonic acidemia","percentRanges":"-"},{"phenoTypeId":2725,"phenoTypeName":"Methylmalonic aciduria","percentRanges":"-"},{"phenoTypeId":6159,"phenoTypeName":"Microtia","percentRanges":"-"},{"phenoTypeId":15514,"phenoTypeName":"Neutropenia","percentRanges":"-"},{"phenoTypeId":15515,"phenoTypeName":"Pancytopenia","percentRanges":"-"},{"phenoTypeId":15512,"phenoTypeName":"Thrombocytopenia","percentRanges":"-"}],"medicalProducts":[{"productId":286,"genericName":"Betaine","tradeName":"Cystadane","tradeLink":"http://www.cystadane.com/","manufacturer":"","sponsor":"Orphan Europe SARL","indication":"Treatment of homocystinuria to decrease elevated homocysteine blood levels.","drugInformationLink":"https://druginfo.nlm.nih.gov/drugportal/rn/107-43-7","medlinePlusLink":"https://medlineplus.gov/druginfo/meds/a608012.html"}],"EncodedName":"Methylmalonic_acidemia_with_homocystinuria_type_cblF"}